Unversity of North Carolina
Chapel Hill, North Carolina, 27599, United States
NCT Number: NCT00407732
The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate candidates for interferon therapy.
Looking for future studies?
Notify Me18 year–70 year
All sexes
Interventional
Not applicable
Chapel Hill, North Carolina, 27599, United States
The purpose of this study is to develop and evaluate a 9-month psychosocial intervention that will assist patients with hepatitis C in overcoming barriers that prevent them from becoming appropriate candidates for interferon therapy. Patients who have been deferred from therapy due to mental health or substance abuse issues will work with the team psychologist on following through with the hepatologist's treatment recommendations that would lead to becoming eligible for interferon therapy.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
motivational enhancing case management intervention
Time frame: 3-, 6-, and 9-months
University of North Carolina, Chapel Hill
Other
Overcoming Neuropsychiatric Barriers to the Treatment of Hepatitis C
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04036396
Bacterial Infections, Bacterial Infections and Mycoses
Los Angeles, California, United States
View Trial DetailsNCT05376371
Blood-Borne Infections, Chemically-Induced Disorders
Oregon, Wisconsin, United States
View Trial DetailsNCT04048850
Acquired Immunodeficiency Syndrome, Blood-Borne Infections
Chicago, Illinois, United States
View Trial DetailsNCT05369507
Blood-Borne Infections, Chemically-Induced Disorders
Greenville, South Carolina, United States
View Trial Details